TELO2 and neurodegenerative disease: Contributes to lysosomal function as well as the viability of neurones (22); mutations in CLN6 have shown to cause neurodegenerative disease (28); CLN6 is also associated with mTOR and TELO2 regulators of signaling pathways that are known to be disrupted by ZIKV (21).